InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
+8.1%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Spiegel Robert J., Director. Insider active across 4 companies, notably Cyclacel Pharmaceuticals, Inc.. Cumulatively, 32 disclosures have been published. Breakdown: 1 buy · 0 sell. Activity tracked since 15 June 2021. The latest transaction was filed on 30 September 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations32 total
1,767 shares@ US$4.5424.5% of flowCommon StockSEC:0000950170-25-049544:0
4,913 shares@ US$1.5924.5% of flowCommon StockSEC:0000950170-25-049594:0
2,206 shares@ US$3.5425.5% of flowCommon StockSEC:0000950170-25-049554:0
2,462 shares@ US$3.3025.6% of flowCommon StockSEC:0000950170-25-049533:0
2,206 shares0Common StockSEC:0000950170-25-000409:0
1,767 shares0Common StockSEC:0000950170-24-110796:0
2,462 shares0Common StockSEC:0000950170-24-079169:0
40,983 sharesCommon StockSEC:0001493152-24-004370:0
Ideal exit: 22 Oct 2024 (T+270)
3,406 shares0Common StockSEC:0001209191-24-000547:0
3,390 shares0Common StockSEC:0001062993-23-018725:0
21,219 shares0Common StockSEC:0001104659-23-077658:0
2,239 shares0Common StockSEC:0001062993-23-014271:0
2,300 shares@ US$1.30519.2% of flowCommon StockSEC:0001209191-23-025408:0
3,312 shares0Common StockSEC:0001062993-23-008378:0
16,130 shares@ US$0.18619.4% of flowCommon StockSEC:0001209191-23-003402:0
2,970 shares0Common StockSEC:0001062993-23-000091:0
12,453 shares@ US$0.240921.5% of flowCommon StockSEC:0001209191-22-053419:0
3,071 shares0Common StockSEC:0001062993-22-020176:0
8,750 sharesCommon StockSEC:0001209191-22-048054:0
4,508 shares@ US$0.665520.6% of flowCommon StockSEC:0001209191-22-042879:0
4,637 shares0Common StockSEC:0001062993-22-015792:0
15,822 shares0Common StockSEC:0001104659-22-071900:0
3,989 shares@ US$0.752100.0% of flowCommon StockSEC:0001209191-22-024050:0
5,284 shares0Common StockSEC:0001062993-22-009237:0
5,891 shares0Common StockSEC:0001062993-22-000082:0
25 of 32 declarations
About Spiegel Robert J.
Robert J. Spiegel is a Board Member at Cyclacel Pharmaceuticals, Inc., Geron Corp, and Athenex, Inc. He brings expertise in biopharmaceuticals and product development to the board. His experience in the pharmaceutical sector contributes to guiding the strategic decisions of the companies.
